Dual-Phase Dual-Energy CT in Patients Treated with Erlotinib for Advanced Non-Small Cell Lung Cancer: Possible Benefits of Iodine Quantification in Response Assessment
Crossref DOI link: https://doi.org/10.1007/s00330-015-4092-6
Published Online: 2015-11-12
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Baxa, Jan
Matouskova, Tana
Krakorova, Gabriela
Schmidt, Bernhard
Flohr, Thomas
Sedlmair, Martin
Bejcek, Jiri
Ferda, Jiri
Text and Data Mining valid from 2015-11-12